Austin, Yuli 19, 2021 (GLOBE NEWSWIRE) - Nasara Medical, asibitin likita dake 4303 Nasara Dr, Austin, TX 78704, yana ba da sa ido na nesa (RPM), sabis na rufe Medicare.RPM yana ba likitoci hanya mai sauƙi don saka idanu marasa lafiya da yanayin lafiya kamar ciwon sukari ko hawan jini ba tare da majiyyaci ya bar gida ba.Don ƙarin bayani game da wannan sabis ɗin, da fatan za a ziyarci: https://victorymed.com/remote-patient-monitoring/.
Don ayyukan RPM, bayan shawarwari mai nisa tare da ƙwararrun RPM na Nasara Medical, ana aika kayan aikin sa ido zuwa gidan majiyyaci.Yin amfani da waɗannan na'urori na gida, ana iya samun glucose da karatun hawan jini cikin sauƙi.Ana watsa karatun ta atomatik zuwa ƙwararren ƙwararren kiwon lafiya na majiyyaci, waɗanda ke sa ido kan kowane canje-canje ko matsaloli masu yuwuwa.Idan majiyyaci yana buƙatar sa baki ko magani, yawanci ana aiwatar da shi ba tare da majinyacin ya ga likita a cikin mutum ba.
Baya ga RPM, Likitan Nasara kuma yana ba da Gudanar da Kulawa na Zamani (CCM).Dukansu RPM da CCM hanyoyi ne masu tasiri don sarrafa cututtuka na yau da kullun.Bambanci ɗaya tsakanin su biyun shine RPM yana amfani da kayan sa ido, yayin da CCM zai sadar da sabuntawar lafiya ta hanyar manajan kulawa.Yawancin marasa lafiya na Medicare za su amfana daga hanyoyin kulawa ɗaya ko biyu.
Dokta William Franklin shine darektan likita kuma wanda ya kafa Nasara Medical a Kudancin Austin, Texas.Ya kasance ma'aikacin kiwon lafiya tun 1983 kuma ya kafa Nasara Medical a 1996. Dr. Franklin ya sami horo na musamman a cikin kula da shekaru, kula da ramuwa na ma'aikata, maganin maye gurbin hormone na halitta, magungunan jaraba, ciki, maganin wasanni, asarar nauyi da kula da nauyi. da kuma gwajin alerji da magani.
Dokta Franklin ya sami digirin digirinsa na likitanci daga Jami'ar Texas Medical Branch (UTMB) a Galveston.Shi farfesa ne na asibiti a Makarantar koyon aikin jinya ta UT Austin kuma abokin malami ne a UTMB.Shi memba ne kuma mai haɗin gwiwa na ƙungiyoyin ƙwararru daban-daban kamar: Cibiyar Nazarin Magunguna ta Amurka;Binciken Ayyukan Iyali na Cibiyar Kiwon Lafiya ta Baylor;Kwamitin Ba da Shawarar Tsarin Iyali;Ƙungiyar Allergy Society;Kwamitin Kula da Lafiyar Likita;da Phi Chi Medical and Service Association.
Dr. Franklin likita ne na iyali wanda ke ba da kulawar rigakafi da kulawa na farko.Dokta Franklin da tawagarsa a Nasara Medical sun yarda da yawancin tsare-tsaren inshora, ciki har da: Medicare, Allied Health Care;Lafiyar Ƙawance;Cibiyar Lafiya ta Alta;AMD;Ba'amurke Ben;Cibiyar Lafiya ta Amurka;Baylor Scott & Tsarin Lafiya na Fari;da sauran su.
Masu sha'awar ƙarin koyo game da ayyukan sa ido na nesa na marasa lafiya da Victory Medical ke bayarwa na iya duba gidan yanar gizon su, tuntuɓar ta waya ko imel, ko duba shafin Facebook na kamfanin.
For more information about Victory Medical, please contact the company here: Victory Medical Bailey Holle(512) 271-2469bholle@victorymed.com4303 Victory DriveAustin, TX 78704
Dangane da bayanan da Standard & Poor's Global suka bayar, bayan da aka samu karuwa mai karfi a cikin watan da ya gabata na 2020, farashin hannun jarin giant mai hakar uranium Cameco (NYSE: CCJ) ya ci gaba da hauhawa a shekarar 2021 kuma ya tashi da kashi 43.1 a farkon rabin wannan shekarar. .%.Hankalin kasuwa.Babban kyakkyawan fata a kasuwar uranium da abubuwan da ke kunno kai a cikin masana'antar da ke taimakawa farashin uranium wasu manyan abubuwan da ke haifar da farashin hannun jari na Cameco.Kamar yadda wannan na iya nufin karuwar bukatar uranium, wani muhimmin makamashin nukiliya, hannayen jarin uranium sun yi tashin gwauron zabi saboda hasashe.Ganin yadda yake jagorantar masana'antar, farashin hannun jari na Cameco ya tashi.
Farashin hannun jari na kamfanin fasahar kere-kere Ocugen (NASDAQ: OCGN) ya tashi kusan kashi 13% a yau yayin da sabbin bayanan COVID ke nuna karuwar adadin lokuta, asibitoci, da mace-mace-musamman wadanda ba a yi musu allurar ba.A cikin makonni biyu da suka gabata, lamuran COVID sun karu da kashi 140%, yayin da asibitoci da mace-mace suka karu da kashi uku.Ocugen ya yi haɗin gwiwa tare da Bharat Biotech, kamfanin da ke da alhakin Covaxin, wanda shine farkon rigakafin gaggawa na COVID da aka haɓaka a Indiya.
Jinkirta a cikin takaddun tsari don rigakafinta na Covid-19 NVX-CoV2373 (NUVAXOVID) yana nufin cewa Novavax (NVAX) bai riga ya samar da samfuran sa ga jama'a ba.Kuna iya tunanin cewa tare da wasu manyan 'yan wasa da ke da tushe a cikin wayewar jama'a da masu tsara manufofin kiwon lafiya, watakila damar yin aiki mai kyau a bara ta wuce.Koyaya, a cikin binciken da aka yi daga baya, bayanan rigakafin sun nuna cewa ya yi kyau kamar yadda manyan bayanan rigakafin da aka amince da su.Tare da EU
A safiyar ranar Litinin, farashin hannayen jarin Cytokinetics, wani karamin kamfanin fasahar kere-kere ya karu da kashi 60 cikin 100, sakamakon binciken da kamfanin ya yi na binciken magungunan cututtukan zuciya.
Muna ƙara jin cewa mutane sun kamu da cutar ta coronavirus bayan an yi musu cikakken allurar rigakafi.Wannan lamari ne mai tayar da hankali a cikin annobar.Sai dai Dr. Anthony Fauci, babban mai ba shugaban kasa shawara kan harkokin kiwon lafiya kuma darekta na Cibiyar Allergy da Cututtuka, ya bayyana a CNN jiya cewa suna tsammanin hakan zai faru.Ci gaba da karatu don sabbin abubuwan guda biyar da tabbatar da lafiyar ku da sauran su.Kada ku rasa waɗannan alamun tabbatacce waɗanda za ku iya samun kamuwa da “dogon lokaci” tare da COVID waɗanda ƙila ba ku sani ba.1
Ƙwararrun malamai na kan layi ko ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun masu sana'a, ayyukan al'adu kyauta lokaci zuwa lokaci, ƙwarewar al'adun ƙasa daban-daban, Prince Tuen Mun Yuen Long Tin Shui Wai Sha Tin Wind Class!
Cytokinetics ya fada a ranar Litinin cewa maganinsa ya inganta kwararar jini a cikin marasa lafiya da ke fama da cututtukan zuciya na gado, wani nau'i na kayan fasahar kere kere.
A wata hira da ya yi da Yahoo Finance, Shugaban Hukumar Kiwon Lafiya ta Clover Vivek Garipalli ya mayar da martani ga sukar da aka yi wa asibitinsa da ke New Jersey.
(Bloomberg) – Cutar sankarau ta haifar da yaduwar bambance-bambancen delta na haifar da ƙararrawa, yana haifar da siyarwa a kasuwannin hannayen jari na duniya.Yayin da ake samun karuwar masu kamuwa da cutar a Burtaniya da Indonesiya, Amurka ta gargadi 'yan kasar da kada su yi balaguro zuwa Burtaniya da Indonesia.Tare da adadin shari'o'in yau da kullun da ke yin rikodin rikodi, Singapore za ta sake tsaurara takunkumi kan cin abinci da taron jama'a.Bayan Kudancin Ostiraliya ta shiga cikin sahun Victoria da New South Wales, rabin mutanen Australiya sun dawo cikin kulle-kulle
Mesoblast Limited (NASDAQ: MESO) ta sanar da rahoton sakamakon tsira na kwanaki 90 na gwajin remestemcel-L da aka gudanar a cikin masu dogaro da iska na COVID-19 masu fama da matsananciyar wahala ta numfashi (ARDS).An buga waɗannan bayanan a cikin Ƙungiyar Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararrun Ƙwararru.Sakamakon ya nuna cewa shan allurai biyu na remestemcel-L a ranakun 3-5 na iya kawo fa'idodin rayuwa mai dorewa.
19 ga Yuli – Ben Cowling, farfesa a fannin cututtukan cututtukan cututtuka a Makarantar Kiwon Lafiyar Jama'a ta Jami'ar Hong Kong, ya ba gwamnati shawara kan tsarin rigakafin kuma ya tattauna ingancin rigakafin.Ya kuma yi magana game da bincikensa, wanda ya nuna babban bambanci a matakan antibody tsakanin BioNTech SE da Sinovac Biotech Ltd. Ya ba da jawabi a kan "Kasuwancin Bloomberg: Asiya".
Dokta Anand Parekh, Babban Mashawarcin Likita na Cibiyar Siyasa ta Bipartisan kuma tsohon Mataimakin Mataimakin Sakatare na Ma'aikatar Lafiya da Ayyukan Jama'a, ya shiga Yahoo Finance don tattauna sabbin labarai game da cutar sankara.
Rage farashi.Dubi nawa zaku iya ajiyewa tare da Saxo.Akwai haɗari a cinikin kayan aikin kuɗi.
Mutanen da ke da masaniya kan lamarin sun fada a ranar Litinin cewa, ana sa ran babban mai shigar da kara na Amurka zai ba da sanarwar sasantawar dala biliyan 26 a wannan mako domin warware zargin cewa manyan dillalan magunguna guda uku da Johnson & Johnson na taimakawa wajen yaduwar cutar ta opioid a fadin kasar.Masu rarraba McKesson Corp, Cardinal Health Inc da AmerisourceBergen Corp za su biya jimillar dalar Amurka biliyan 21, yayin da Johnson & Johnson za su biya dalar Amurka biliyan 5.
Arrowhead Pharmaceuticals (NASDAQ: ARWR) wani kamfani ne na ci gaban fasahar kere-kere da ke mayar da hankali kan tsangwama na RNA (RNAi).Kamfanin yana da 'yan takarar magunguna 9 a cikin gwaji na asibiti, gami da yuwuwar ilimin halittu guda uku waɗanda aka haɓaka tare da reshen Johnson & Johnson's Janssen.Hannun jarin ya ninka fiye da sau biyu a shekara a watan Yuni zuwa $90 a kowace rabon, amma bayan da kamfanin ya sanar a ranar 6 ga Yuli cewa zai dakatar da gwajin gwaji na Phase 1/2 don nazarin ARO-ENaC don maganin cystic fibrosis, farashin hannun jari. ya fi girma Ya fadi da kusan kashi 30%.
Worth da Farrell Fritz abokin tarayya Domenique Camacho Moran sun zauna don tattaunawa kan haƙƙoƙin da ke da alaƙa da komawa ofis bayan barkewar duniya.Shin masu daukar ma'aikata na iya buƙatar ma'aikata su yi allurar rigakafi?Ƙari ga haka, amsoshin wasu tambayoyin doka sun fara bayyana a kan Worth lokacin da muka dawo ofis.
Chengri yana jin rashin jin daɗi ko'ina, amma ina mamakin dalilin da yasa yana iya kasancewa da alaƙa da lafiyar hankali![1] Yi gwajin PHQ-9 nan da nan, kuma za ku iya samun kyakkyawar fahimta game da lafiyar tunanin ku mai baƙin ciki tare da gwaje-gwaje masu sauƙi guda 10.
Tawaga daga Ma'aikatar Lafiya da Jin Dadin Jama'a na Japan sun goyi bayan amfani da gaggawa na Moderna Inc's (NASDAQ: MRNA) rigakafin COVID-19 ga yara masu shekaru 12 zuwa 17, suna ba da hanyar samun izini na ƙarshe daga Ma'aikatar Lafiya a cikin kwanaki masu zuwa.Kungiyar ta ba da shawarar rage yawan shekarun da ake yi yanzu na shekaru 18 zuwa sama ba tare da buƙatar ƙarin gwajin asibiti a ƙasar ba.Pfizer (NYSE: PFE)-Tun watan Yuni, an ba da izinin rigakafin BioNTech SE (NASDAQ: BNTX) don amfani da gaggawa a cikin yara masu shekaru 12 da haihuwa.
Jami'an kiwon lafiya na kasar Sin sun bayyana a cikin wani rahoto a ranar Asabar cewa, wani dan kasar Sin ya mutu bayan ya kamu da wata cuta mai saurin kisa, kwayar cutar biri B.Wanda aka kashen wani likitan dabbobi ne dan shekaru 53 a birnin Beijing wanda shi ne mutum na farko da aka samu kamuwa da cutar a China.A cewar Cibiyar Kula da Cututtuka ta kasar Sin, mutumin ya yi aiki a wata cibiyar bincike da ta kware wajen haifuwa da dabbobin da ba na mutane ba, ya kuma rarraba matattun birai guda biyu a watan Maris.Yana jin rashin lafiya,
Yayin da masu saka hannun jari suka kasance cikin natsuwa game da hauhawar kamuwa da cutar ta Covid-19 a cikin Amurka da ma duniya baki daya, kasuwa ta girgiza ranar Litinin, wanda ya haifar da fargabar cewa murmurewa na iya ƙarewa kafin a fara da gaske.Sai dai bayanai daga Burtaniya sun nuna cewa mutane da dama da suka kamu da cutar sun riga sun yi allurar riga-kafi ko wani bangare.
Ana samun karuwar allurar rigakafi a Faransa, kuma mutane sun fusata game da manufar yin allurar riga-kafi ko gwaji mara kyau don zuwa wuraren shaye-shaye, kallon fina-finai, daukar jiragen kasa, da sauransu a wata mai zuwa.: A cewar rahotanni, zanga-zangar da aka yi a fadin kasar ta janyo hankulan mutane sama da 100,000 a karshen mako kuma an lalata cibiyoyin rigakafin guda biyu.Samu labaran kasuwa masu darajar lokacinku tare da Kasuwannin Axios.Biyan kuɗi kyauta.Matsayin wasa: duk da kasancewa ɗaya daga cikin mafi yawan zargin allurar rigakafi a duniya
Lokacin aikawa: Yuli-20-2021